Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-097267
Filing Date
2015-03-19
Accepted
2015-03-18 19:19:39
Documents
17
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d889139d10k.htm 10-K 1398640
2 EX-23.1 d889139dex231.htm EX-23.1 1392
3 EX-31.1 d889139dex311.htm EX-31.1 7812
4 EX-31.2 d889139dex312.htm EX-31.2 7813
5 EX-32.1 d889139dex321.htm EX-32.1 4608
6 EX-32.2 d889139dex322.htm EX-32.2 4610
7 GRAPHIC g889139g00f45.jpg GRAPHIC 53385
8 GRAPHIC g889139g25r59.jpg GRAPHIC 81611
9 GRAPHIC g889139g29c92.jpg GRAPHIC 66535
10 GRAPHIC g889139g37y24.jpg GRAPHIC 36286
11 GRAPHIC g889139g45q78.jpg GRAPHIC 123101
12 GRAPHIC g889139g51h92.jpg GRAPHIC 44523
13 GRAPHIC g889139g56h04.jpg GRAPHIC 91110
14 GRAPHIC g889139g60h16.jpg GRAPHIC 44662
15 GRAPHIC g889139g63i82.jpg GRAPHIC 54136
16 GRAPHIC g889139g64a44.jpg GRAPHIC 25884
17 GRAPHIC g889139g65i58.jpg GRAPHIC 38881
  Complete submission text file 0001193125-15-097267.txt   2337042
Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Filer) CIK: 0001594864 (see all company filings)

EIN.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36781 | Film No.: 15711347
SIC: 2836 Biological Products, (No Diagnostic Substances)